Announcements Trials
Browse Landscape

Phase

Phase 2 118Phase NA 33Phase 3 33Phase 1/2 17Phase 4 14Phase 2/3 14Phase 1 9Phase EARLY_PHASE1 1

Status

Recruiting 2Completed 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Successful Conversion Rate of Operation 1

Interventions

fludarabine 17Cyclophosphamide 16Positron Emission Tomography Computed Tomography 4Oncolytic Virotherapy 4Metformin 468Ga-pentixafor 4lenvatinib 3Radiosurgery 3Pemetrexed 3Paclitaxel 3Melphalan 3Immunotherapy, Adoptive 3Gemcitabine 3Cholestanetriol 26-Monooxygenase 3Carboplatin 3toripalimab 2sintilimab 2pembrolizumab 2gallium Ga 68 dotatate 2gallium 68 PSMA-11 2fludarabine phosphate 2alpha-Synuclein 2Progesterone 2Nivolumab 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Influenza Vaccines 2Fluorodeoxyglucose F18 2Ethiodized Oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Drug Therapy × Clear all
NCT03822130 2019-02-20

Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate for Unresectable Gastric Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase EARLY_PHASE1 Unknown
150 enrolled
Gastrointestinal

Successful Conversion Rate of Operation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡